Pan Cancer T

Pan Cancer T company information, Employees & Contact Information

Explore related pages

Related company profiles:

Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges.

Company Details

Employees
12
Founded
-
Address
Marconistraat 16, Rotterdam,south Holland 3029,netherlands
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Rotterdam, South Holland
Looking for a particular Pan Cancer T employee's phone or email?

Pan Cancer T Questions

News

Functional tumor-reactive CD8 + T cells in pancreatic cancer - Journal of Experimental & Clinical Cancer Research

Functional tumor-reactive CD8 + T cells in pancreatic cancer Journal of Experimental & Clinical Cancer Research

Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition - Science | AAAS

Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition Science | AAAS

What To Know About Pancreatic Cancer - Memorial Sloan Kettering Cancer Center

What To Know About Pancreatic Cancer Memorial Sloan Kettering Cancer Center

Nanoparticle immune therapy shows potential in mice to treat and prevent spread of pancreatic cancer to liver - Newsroom | UCLA

Nanoparticle immune therapy shows potential in mice to treat and prevent spread of pancreatic cancer to liver Newsroom | UCLA

A pan-cancer atlas of T cell targets - Oncodaily

A pan-cancer atlas of T cell targets Oncodaily

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer - Nature

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer Nature

Pancreatic Cancer Spreads to Liver or Lung Thanks to This Protein - UC San Francisco

Pancreatic Cancer Spreads to Liver or Lung Thanks to This Protein UC San Francisco

New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy - OHSU News

New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy OHSU News

Precision Medicine: Pancreatic Cancer Clinical Research - Froedtert & MCW

Precision Medicine: Pancreatic Cancer Clinical Research Froedtert & MCW

Pan Cancer T and NecstGen Collaborate to Accelerate Novel TCR-T Therapies into Clinical Development - BioInformant

Pan Cancer T and NecstGen Collaborate to Accelerate Novel TCR-T Therapies into Clinical Development BioInformant

Pan Cancer T secures €4.25 Million in Seed Extension Round to advance next-generation T cell therapies - GlobeNewswire

Pan Cancer T secures €4.25 Million in Seed Extension Round to advance next-generation T cell therapies GlobeNewswire

In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group - Memorial Sloan Kettering Cancer Center

In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group Memorial Sloan Kettering Cancer Center

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer - The New England Journal of Medicine

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer The New England Journal of Medicine

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance - Nature

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Nature

The Potential of CAR T Cell Therapy in Pancreatic Cancer - Frontiers

The Potential of CAR T Cell Therapy in Pancreatic Cancer Frontiers

Killing Pancreatic Cancer with T Cells that Supercharge Themselves - UC San Francisco

Killing Pancreatic Cancer with T Cells that Supercharge Themselves UC San Francisco

Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report - Frontiers

Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report Frontiers

Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7 - Nature

Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7 Nature

Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing - Nature

Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing Nature

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - Nature

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer Nature

Advances in Pancreatic Cancer Research - NCI - National Cancer Institute (.gov)

Advances in Pancreatic Cancer Research - NCI National Cancer Institute (.gov)

Pan-cancer proteogenomics connects oncogenic drivers to functional states - ScienceDirect.com

Pan-cancer proteogenomics connects oncogenic drivers to functional states ScienceDirect.com

Increased glucose availability sensitizes pancreatic cancer to chemotherapy - Nature

Increased glucose availability sensitizes pancreatic cancer to chemotherapy Nature

Barriers and opportunities in pancreatic cancer immunotherapy - Nature

Barriers and opportunities in pancreatic cancer immunotherapy Nature

Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response - Nature

Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response Nature

Providers make slow but steady progress to improve pancreatic cancer survival rates - UCHealth

Providers make slow but steady progress to improve pancreatic cancer survival rates UCHealth

Pancreatic cancer - Symptoms and causes - Mayo Clinic

Pancreatic cancer - Symptoms and causes Mayo Clinic

Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment - Nature

Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment Nature

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy - ScienceDirect.com

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy ScienceDirect.com

An mRNA vaccine to treat pancreatic cancer - National Institutes of Health (.gov)

An mRNA vaccine to treat pancreatic cancer National Institutes of Health (.gov)

Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy - The Lancet

Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy The Lancet

A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing - Nature

A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing Nature

Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application - Frontiers

Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application Frontiers

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models - MD Anderson Cancer Center

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models MD Anderson Cancer Center

The road to overcome pancreatic cancer: Where are we? - ScienceDirect.com

The road to overcome pancreatic cancer: Where are we? ScienceDirect.com

KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells - ScienceDirect.com

KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells ScienceDirect.com

Pancreatic Cancer Finds Alternate Fuel for Survival, Growth - National Cancer Institute (.gov)

Pancreatic Cancer Finds Alternate Fuel for Survival, Growth National Cancer Institute (.gov)

In pancreatic cancer, a race against time - Cold Spring Harbor Laboratory

In pancreatic cancer, a race against time Cold Spring Harbor Laboratory

‘How I knew I had pancreatic cancer’: Survivors share their symptoms - MD Anderson Cancer Center

‘How I knew I had pancreatic cancer’: Survivors share their symptoms MD Anderson Cancer Center

I’m Still Standing: Surviving Pancreatic Cancer for Three Years! - Froedtert & MCW

I’m Still Standing: Surviving Pancreatic Cancer for Three Years! Froedtert & MCW

The Link Between Pancreatic Cancer and Diabetes - Cedars-Sinai

The Link Between Pancreatic Cancer and Diabetes Cedars-Sinai

microRNA-Based Liquid Biopsy Detects Early Pancreatic Cancer - National Cancer Institute (.gov)

microRNA-Based Liquid Biopsy Detects Early Pancreatic Cancer National Cancer Institute (.gov)

FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer: What You Need to Know - Pancreatic Cancer Action Network

FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer: What You Need to Know Pancreatic Cancer Action Network

Clinical Trials - Pancreatic Cancer Action Network

Clinical Trials Pancreatic Cancer Action Network

Diabetes and pancreatic cancer: What is the link? - MD Anderson Cancer Center

Diabetes and pancreatic cancer: What is the link? MD Anderson Cancer Center

MRTX1133 Targets Tumors with KRAS G12D Mutations - National Cancer Institute (.gov)

MRTX1133 Targets Tumors with KRAS G12D Mutations National Cancer Institute (.gov)

How Did You Discover You Had Pancreatic Cancer? - Froedtert & MCW

How Did You Discover You Had Pancreatic Cancer? Froedtert & MCW

Pancreatic Cancer Early Detection - Pancreatic Cancer Action Network

Pancreatic Cancer Early Detection Pancreatic Cancer Action Network

Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation - ScienceDirect.com

Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation ScienceDirect.com

Is pancreatic cancer hereditary? 9 things to know - MD Anderson Cancer Center

Is pancreatic cancer hereditary? 9 things to know MD Anderson Cancer Center

Pancreatic Cancer Five-Year Survival Rate Increases to 13% - Pancreatic Cancer Action Network

Pancreatic Cancer Five-Year Survival Rate Increases to 13% Pancreatic Cancer Action Network

New-Onset Diabetes: An Early Sign of Pancreatic Cancer? - National Cancer Institute (.gov)

New-Onset Diabetes: An Early Sign of Pancreatic Cancer? National Cancer Institute (.gov)

A Leading Surgeon Helps Patients with Pancreatic Cancer Overcome Steep Odds - NYU Langone Health

A Leading Surgeon Helps Patients with Pancreatic Cancer Overcome Steep Odds NYU Langone Health

Pancreatic Cancer Diet, Food and Nutrition - PanCAN - Pancreatic Cancer Action Network

Pancreatic Cancer Diet, Food and Nutrition - PanCAN Pancreatic Cancer Action Network

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics - ScienceDirect.com

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics ScienceDirect.com

14 Pancreatic Cancer Warning Signs - Pancreatic Cancer Action Network

14 Pancreatic Cancer Warning Signs Pancreatic Cancer Action Network

There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that - CNN

There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that CNN

Major Strides in Pancreatic Cancer Give ‘Actual Reasons for Hope’ - michiganmedicine.org

Major Strides in Pancreatic Cancer Give ‘Actual Reasons for Hope’ michiganmedicine.org

5 Things to Know About Targeting Mutant KRAS in Pancreatic Cancer - Pancreatic Cancer Action Network

5 Things to Know About Targeting Mutant KRAS in Pancreatic Cancer Pancreatic Cancer Action Network

Five-Year Survival Rate for Pancreatic Cancer Increased to 13% Signaling More Progress and More Hope for Patients - Pancreatic Cancer Action Network

Five-Year Survival Rate for Pancreatic Cancer Increased to 13% Signaling More Progress and More Hope for Patients Pancreatic Cancer Action Network

Why Can’t We Stop Pancreatic Cancer? (Published 2019) - The New York Times

Why Can’t We Stop Pancreatic Cancer? (Published 2019) The New York Times

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine - The New England Journal of Medicine

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine The New England Journal of Medicine

5 Things to Know About Stage IV Pancreatic Cancer - Pancreatic Cancer Action Network

5 Things to Know About Stage IV Pancreatic Cancer Pancreatic Cancer Action Network

Friday Fix: Anemia and Pancreatic Cancer - Pancreatic Cancer Action Network

Friday Fix: Anemia and Pancreatic Cancer Pancreatic Cancer Action Network

Why pancreatic cancer is so deadly - CNN

Why pancreatic cancer is so deadly CNN

Why Is Pancreatic Cancer So Deadly? - Scientific American

Why Is Pancreatic Cancer So Deadly? Scientific American

Top Pan Cancer T Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant